| Advances in non-viral DNA vectors for gene therapy CL Hardee, LM Arévalo-Soliz, BD Hornstein, L Zechiedrich Genes 8 (2), 65, 2017 | 385 | 2017 |
| Modification of hematopoietic stem/progenitor cells with CD19-specific chimeric antigen receptors as a novel approach for cancer immunotherapy SN De Oliveira, C Ryan, F Giannoni, CL Hardee, I Tremcinska, ... Human gene therapy 24 (10), 824-839, 2013 | 109 | 2013 |
| Allelic exclusion and peripheral reconstitution by TCR transgenic T cells arising from transduced human hematopoietic stem/progenitor cells F Giannoni, CL Hardee, J Wherley, E Gschweng, S Senadheera, ... Molecular Therapy 21 (5), 1044-1054, 2013 | 79 | 2013 |
| CD4+ CD25− T cells transduced to express MHC class I-restricted epitope-specific TCR synthesize Th1 cytokines and exhibit MHC class I-restricted cytolytic effector function in … A Chhabra, L Yang, P Wang, B Comin-Anduix, R Das, NG Chakraborty, ... The Journal of Immunology 181 (2), 1063-1070, 2008 | 59 | 2008 |
| Dosing and re-administration of lentiviral vector for in vivo gene therapy in rhesus monkeys and ADA-deficient mice DA Carbonaro-Sarracino, AF Tarantal, CCI Lee, ML Kaufman, S Wandro, ... Molecular Therapy-Methods & Clinical Development 16, 78-93, 2020 | 13 | 2020 |
| Effects of vector backbone and pseudotype on lentiviral vector-mediated gene transfer: studies in infant ADA-deficient mice and rhesus monkeys DC Sarracino, AF Tarantal, CCI Lee, M Martinez, X Jin, X Wang, ... Molecular Therapy 22 (10), 1803-1816, 2014 | 11 | 2014 |
| Improving therapeutic potential of non-viral minimized DNA vectors LM Arévalo-Soliz, CL Hardee, JM Fogg, NR Corman, C Noorbakhsh, ... Cell & gene therapy insights 6 (10), 1489, 2020 | 10 | 2020 |
| Lentiviral vectors with amplified β cell-specific gene expression KL Shaw, E Pais, S Ge, C Hardee, D Skelton, RP Hollis, GM Crooks, ... Gene therapy 16 (8), 998-1008, 2009 | 10 | 2009 |
| Regulated expansion of human pancreatic β-cells E Pais, J Park, T Alexy, V Nikolian, S Ge, K Shaw, S Senadheera, ... Molecular Therapy 18 (7), 1389-1396, 2010 | 6 | 2010 |
| 466. Attenuated CTLA-4 Inhibition in CD19-Targeted T Cells Expressing a Second-Generation CD28-Based Chimeric Antigen Receptor F Giannoni, CL Hardee, J Wherley, IB Bahner, R Hollis, V Gersuk, X Wang, ... Molecular Therapy 20, 1, 2012 | 1 | 2012 |
| Generation of Antigen Specific T Cells from Human Hematopoietic Stem/Progenitor Cells (HSPC) Transduced with the cDNA for a T Cell Receptor Specific for the MART-1 Antigen F Giannoni, CL Hardee, J Wherley, IB Bahner, R Hollis, V Gersuk, X Wang, ... MOLECULAR THERAPY 20, S181-S181, 2012 | | 2012 |
| Gene Transfer to Hematopoietic Stem/Progenitor Cells As a Novel Approach for Immunotherapy Against B-Lineage Malignancies: In Vivo Xenograft Model SN De Oliveira, F Giannoni, C Hardee, A Sahaghian, LJN Cooper, ... Blood, The Journal of the American Society of Hematology 118 (21), 4168-4168, 2011 | | 2011 |
| Lentiviral Vector-Mediated Gene Transfer In Vivo in Adenosine Deaminase (ADA)-Deficient Mice and Rhesus Monkeys: Effects of Vector Backbone and Pseudotype DA Carbonaro, AF Tarental, CCI Lee, RP Hollis, DC Skelton, C Hardee, ... MOLECULAR THERAPY 17, S11-S11, 2009 | | 2009 |
| Lentiviral Vector Designed To Induce the Controlled Expansion of Pancreatic Beta Cells E Pais, J Park, S Ge, K Shaw, S Senadheera, CL Hardee, DC Skelton, ... MOLECULAR THERAPY 17, S296-S296, 2009 | | 2009 |
